Article Information
History
- March 26, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Joshua W.D. Tobin1,2,†,
- Anna Crothers3,†,
- Ti Eric Ma4,
- Peter Mollee1,4,
- Maher K. Gandhi1,2,
- Paul Scuffham3 and
- Greg Hapgood1,4,*
- 1Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
- 2Mater Research Institute, University of Queensland, Brisbane, Queensland, Australia
- 3Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia
- 4University of Queensland, Brisbane, Queensland, Australia
- ↵*Corresponding author
Dr Greg Hapgood, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba 4102, Brisbane, Australia, greg.hapgood{at}health.qld.gov.au, P +61 7 3176 2111 F +61 7 3176 7042
Posted March 26, 2021.
A cost-effectiveness analysis of front-line treatment strategies in early stage follicular lymphoma
